NASDAQ · XTLB
XTL Biopharmaceuticals Ltd.
Healthcare · Biotechnology
$2.02
Down-$0.16 (-7.34%)
Updated Oct 7, 2026, 11:29 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.63M
- P/E ratio
- -4.03
- Dividend yield
- 0.00%
- 52-week range
- $2.01 – $10.28
- Volume
- 36.96K
- Avg. volume
- 813.17K
Price performance · XTLB
XTLB price history
1M range · 18 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
XTLB closed at $2.02 after 18 trading sessions, down 20.16% for the selected period.
- Last close
- $2.02
- Period change
- -20.16%
- Period low
- $2.02
- Period high
- $2.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $2.17 | $2.26 | $2.02 | $2.02 | 36.96K |
| Oct 5, 2026 | $2.20 | $2.355 | $2.17 | $2.18 | 12.93K |
| Oct 2, 2026 | $2.17 | $2.2126 | $2.16 | $2.16 | 6.74K |
| Oct 1, 2026 | $2.42 | $2.42 | $2.13 | $2.13 | 7.14K |
| Sep 30, 2026 | $2.325 | $2.325 | $2.30 | $2.30 | 1.56K |
| Sep 29, 2026 | $2.2643 | $2.2816 | $2.11 | $2.2099 | 24.25K |
| Sep 28, 2026 | $2.27 | $2.44 | $2.23 | $2.23 | 3.64K |
| Sep 25, 2026 | $2.30 | $2.43 | $2.2001 | $2.2001 | 1.04K |
| Sep 24, 2026 | $2.22 | $2.50 | $2.22 | $2.4101 | 13.27K |
| Sep 23, 2026 | $2.39 | $2.4043 | $2.2001 | $2.2001 | 2.54K |
| Sep 21, 2026 | $2.27 | $2.3784 | $2.1859 | $2.3784 | 750.05 |
| Sep 17, 2026 | $2.40 | $2.40 | $2.35 | $2.40 | 3K |
| Sep 16, 2026 | $2.4788 | $2.49 | $2.38 | $2.39 | 1.73K |
| Sep 15, 2026 | $2.40 | $2.4999 | $2.28 | $2.4999 | 5.34K |
| Sep 14, 2026 | $2.47 | $2.51 | $2.40 | $2.43 | 2.22K |
| Sep 11, 2026 | $2.475 | $2.559 | $2.465 | $2.559 | 1.6K |
| Sep 9, 2026 | $2.436 | $2.5602 | $2.40 | $2.52 | 6.26K |
| Sep 8, 2026 | $2.5297 | $2.53 | $2.5297 | $2.53 | 666.55 |
Latest XTLB news
The latest Smart Investors Daily articles mentioning XTLB.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News
Loading stock research…
